- Home
- INMB vs EHTH Comparison
INMB vs EHTH Comparison
Compare INMB & EHTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INMB
- EHTH
- Stock Information
- Founded
- INMB 2015
- EHTH 1997
- Country
- INMB United States
- EHTH United States
- Employees
- INMB N/A
- EHTH N/A
- Industry
- INMB Biotechnology: Pharmaceutical Preparations
- EHTH Specialty Insurers
- Sector
- INMB Health Care
- EHTH Finance
- Exchange
- INMB Nasdaq
- EHTH Nasdaq
- Market Cap
- INMB 176.5M
- EHTH 176.1M
- IPO Year
- INMB 2019
- EHTH 2006
- Fundamental
- Price
- INMB $7.42
- EHTH $4.11
- Analyst Decision
- INMB Strong Buy
- EHTH Hold
- Analyst Count
- INMB 3
- EHTH 5
- Target Price
- INMB $24.33
- EHTH $7.60
- AVG Volume (30 Days)
- INMB 274.4K
- EHTH 387.3K
- Earning Date
- INMB 05-08-2025
- EHTH 05-07-2025
- Dividend Yield
- INMB N/A
- EHTH N/A
- EPS Growth
- INMB N/A
- EHTH N/A
- EPS
- INMB N/A
- EHTH N/A
- Revenue
- INMB $50,000.00
- EHTH $552,565,000.00
- Revenue This Year
- INMB N/A
- EHTH $1.75
- Revenue Next Year
- INMB $43,178.43
- EHTH $7.07
- P/E Ratio
- INMB N/A
- EHTH N/A
- Revenue Growth
- INMB N/A
- EHTH 17.04
- 52 Week Low
- INMB $4.32
- EHTH $3.58
- 52 Week High
- INMB $10.50
- EHTH $11.36
- Technical
- Relative Strength Index (RSI)
- INMB 48.52
- EHTH 35.51
- Support Level
- INMB $7.15
- EHTH $4.28
- Resistance Level
- INMB $8.06
- EHTH $5.66
- Average True Range (ATR)
- INMB 0.45
- EHTH 0.27
- MACD
- INMB -0.01
- EHTH 0.01
- Stochastic Oscillator
- INMB 27.62
- EHTH 6.75
About INMB INmune Bio Inc. Common stock
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products includeINKmune, INBO3, XPro1595, LIVNate, and others.
About EHTH eHealth Inc.
eHealth Inc is a company involved in private health insurance marketplace with a technology and service platform that provides consumer engagement, education and health insurance enrollment solutions. The company operates its business in two segments: Medicare which provides health insurance plans and lesser extent ancillary products such as dental and vision insurance and hospital indemnity plans, to medicare eligible consumers; and Employer and Individual provides individual and family health insurance, and small business health insurance plans and Individual Coverage Health Reimbursement Arrangements. It derives maximum revenue from Medicare Segment. All of the company's revenue is from the United States. It also has a presence in China.